Community Academic Profiles

Harry B Greenberg

Publication Details

  • Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge.

    Mackow ER, Vo PT, Broome R, Bass D, Greenberg HB. J Virol. 1990; 64 (4): 1698-703

    A baculovirus-expressed VP4 protein derived from the simian rhesus rotavirus (RRV) was used to parenterally immunize murine dams. VP4-immunized dams developed high levels of neutralizing antibodies against RRV and low levels of cross-reactive neutralizing antibodies against human strains Wa, ST3, and S2 and animal strains SA-11, NCDV, and Eb. Newborn mice suckled on VP4-immunized dams were protected against a virulent challenge dose of the simian strain RRV and against murine rotavirus Eb. The cross-reactive nature of the serum-neutralizing response generated by VP4 immunization and the protective efficacy of the immunization suggest that recombinant-expressed VP4 proteins should be considered as viable vaccine candidates.

    PubMedID: 2157052

Stanford Medicine Resources:

Footer Links: